Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| INTZ | INTRUSION INC | United States | $3.73M | 1,944,675 | 8.92% | 91.08% | Net Buying | Net Buying |
| ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $7.88M | 439,926,480 | 0.79% | 0.00% | ||
| PPBT | PURPLE BIOTECH LTD | Israel | $10.24M | 198,386,080 | 1.23% | 0.00% | ||
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $5.69M | 35,538,034 | 5.35% | 49.17% | Net Selling | Net Buying |
| IQ | IQIYI INC | China | $4.63B | 6,716,137,085 | 4.53% | 0.00% | ||
| CLNN | CLENE INC | United States | $44.44M | 128,430,098 | 9.06% | 52.75% | Net Buying | Net Selling |
| LIFE | ATYR PHARMA INC | United States | $108.06M | 67,750,024 | 60.86% | 22.55% | Net Buying | Net Selling |
| AGEN | AGENUS INC | United States | $173.85M | 20,946,004 | 63.15% | 36.85% | Net Buying | Net Buying |
| BPTH | BIO-PATH HOLDINGS INC | United States | $1.79M | 678,795 | 3.24% | 96.76% | ||
| GOEV | CANOO INC | United States | $173.87M | 64,397,326 | 44.63% | 55.37% | Net Buying | Net Selling |
| BIOL | BIOLASE INC | United States | $4.81M | 32,522,593 | 0.92% | 56.96% | ||
| KZR | KEZAR LIFE SCIENCES INC | United States | $57.51M | 72,801,359 | 67.83% | 21.82% | Net Buying | |
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $50.67M | 35,686,279 | 13.69% | 8.02% | Net Selling | Net Selling |
| APTO | APTOSE BIOSCIENCES INC | Canada | $18.23M | 15,717,701 | 7.58% | 67.78% | Net Buying | |
| OCUP | OCUPHIRE PHARMA INC | United States | $38.09M | 24,813,370 | 1.23% | 98.77% | Net Buying | Net Buying |
| GOSS | GOSSAMER BIO INC | United States | $151.14M | 225,582,250 | 86.47% | 13.53% | Net Buying | Net Selling |
| BNED | BARNES & NOBLE EDUCATION INC | United States | $11.00M | 53,156,369 | 22.27% | 77.73% | Net Selling | |
| APLM | APOLLOMICS INC | United States | $42.15M | 89,495,790 | 9.89% | 0.00% | ||
| AADI | AADI BIOSCIENCE INC | United States | $41.25M | 24,554,205 | 26.99% | 73.01% | Net Selling | Net Selling |
| MVST | MICROVAST HOLDINGS INC | United States | $123.08M | 317,206,095 | 20.63% | 31.20% | Net Selling | |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.40M | 3,069,516 | 1.86% | 98.14% | Net Buying | |
| IFRX | INFLARX NV | Germany | $81.85M | 58,883,272 | 29.00% | 0.00% | ||
| GEVO | GEVO INC | United States | $143.58M | 240,499,833 | 35.11% | 10.95% | Net Selling | |
| MIST | MILESTONE PHARMACEUTICALS INC | Canada | $83.98M | 53,149,778 | 33.44% | 24.16% | ||
| YTEN | YIELD10 BIOSCIENCE INC | United States | $3.68M | 15,401,706 | 2.09% | 97.91% | Net Buying | Net Buying |
| IMRX | IMMUNEERING CORP | United States | $41.88M | 29,283,272 | 53.75% | 46.25% | Net Selling | Net Selling |
| GNLX | GENELUX CORP | United States | $89.19M | 26,865,473 | 21.54% | 5.21% | Net Selling | Net Selling |
| MRNS | MARINUS PHARMACEUTICALS INC | United States | $77.59M | 54,642,580 | 81.93% | 18.07% | Net Buying | Net Buying |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $33.26M | 39,272,434 | 3.63% | 96.37% | Net Buying | Net Selling |
| TARA | PROTARA THERAPEUTICS INC | United States | $34.87M | 11,433,837 | 11.95% | 88.05% | Net Selling | |
| FEMY | FEMASYS INC | United States | $29.39M | 22,099,347 | 6.42% | 8.05% | ||
| INAB | IN8BIO INC | United States | $45.02M | 43,287,325 | 19.83% | 52.04% | Net Buying | |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $125.10M | 31,913,887 | 39.98% | 60.02% | Net Buying | Net Buying |
| EVA | ENVIVA INC | United States | $40.23M | 74,496,537 | 27.69% | 72.31% | Net Selling | Net Selling |
| NTBL | NOTABLE LABS LTD | Israel | $8.66M | 9,018,261 | 2.63% | 97.37% | Net Selling | |
| SYBX | SYNLOGIC INC | United States | $21.66M | 11,646,977 | 3.98% | 96.02% | Net Selling | Net Selling |
| CVKD | CADRENAL THERAPEUTICS INC | United States | $6.79M | 16,008,469 | 3.45% | 46.72% | Net Buying | |
| MBRX | MOLECULIN BIOTECH INC | United States | $9.60M | 2,227,516 | 45.78% | 54.22% | Net Buying | |
| LUMO | LUMOS PHARMA INC | United States | $22.38M | 8,107,121 | 17.70% | 82.30% | Net Buying | Net Buying |
| VOR | VOR BIOPHARMA INC | United States | $115.89M | 68,168,771 | 87.43% | 10.18% | Net Selling | Net Selling |
| GRTS | GRITSTONE BIO INC | United States | $74.92M | 98,065,594 | 42.92% | 22.23% | Net Buying | |
| PRST | PRESTO AUTOMATION INC | United States | $13.49M | 80,791,967 | 8.56% | 68.69% | Net Buying | |
| PASG | PASSAGE BIO INC | United States | $67.83M | 55,598,796 | 43.60% | 56.40% | Net Buying | Net Selling |
| SPRB | SPRUCE BIOSCIENCES INC | United States | $28.85M | 41,149,160 | 63.59% | 36.41% | Net Selling | Net Selling |
| PSTX | POSEIDA THERAPEUTICS INC | United States | $197.80M | 96,489,127 | 46.85% | 40.59% | Net Selling | Net Selling |
| FBIO | FORTRESS BIOTECH INC | United States | $33.08M | 19,234,526 | 24.35% | 62.68% | Net Buying | Net Buying |
| IKNA | IKENA ONCOLOGY INC | United States | $63.22M | 48,258,111 | 66.60% | 18.22% | ||
| TPST | TEMPEST THERAPEUTICS INC | United States | $77.23M | 22,192,026 | 4.15% | 95.85% | ||
| PGEN | PRECIGEN INC | United States | $348.49M | 248,919,096 | 25.15% | 73.06% | Net Buying | Net Selling |
| HOOK | HOOKIPA PHARMA INC | United States | $79.75M | 98,950,107 | 35.22% | 26.83% | Net Buying | |
| IVA | INVENTIVA SA | France | $164.69M | 52,115,807 | 9.33% | 0.00% | ||
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $504.83M | 64,227,371 | 35.78% | 53.62% | Net Selling | Net Selling |
| AMPX | AMPRIUS TECHNOLOGIES INC | United States | $147.47M | 91,597,817 | 4.85% | 78.15% | Net Selling | Net Buying |
| CLRB | CELLECTAR BIOSCIENCES INC | United States | $97.43M | 32,260,510 | 26.67% | 12.70% | ||
| CARA | CARA THERAPEUTICS INC | United States | $38.26M | 54,656,413 | 44.64% | 53.42% | Net Selling | Net Selling |
| EOSE | EOS ENERGY ENTERPRISES INC | United States | $151.58M | 202,645,716 | 46.82% | 14.22% | Net Selling | Net Selling |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $106.58M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| ACET | ADICET BIO INC | United States | $148.70M | 82,153,984 | 40.62% | 19.50% | Net Buying | |
| AMLX | AMYLYX PHARMACEUTICALS INC | United States | $120.65M | 67,782,139 | 52.42% | 47.58% | Net Buying | Net Selling |
| LUXH | LUXURBAN HOTELS INC | United States | $47.67M | 41,814,361 | 7.28% | 85.94% | Net Buying | |
| REPL | REPLIMUNE GROUP INC | United States | $377.53M | 61,387,786 | 67.71% | 32.29% | Net Selling | |
| CMPX | COMPASS THERAPEUTICS INC | United States | $203.63M | 137,589,171 | 62.59% | 12.24% | Net Buying | Net Selling |
| UBX | UNITY BIOTECHNOLOGY INC | United States | $24.84M | 16,786,647 | 25.70% | 51.52% | Net Selling | Net Selling |
| ESPR | ESPERION THERAPEUTICS INC | United States | $368.25M | 185,052,705 | 38.79% | 21.23% | Net Buying | |
| VERV | VERVE THERAPEUTICS INC | United States | $520.11M | 83,619,279 | 62.25% | 37.75% | Net Buying | Net Selling |
| LQR | LQR HOUSE INC | United States | $4.68M | 4,829,438 | 0.21% | 38.07% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.